{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:29:27Z","timestamp":1786476567994,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007639","name":"Maire Taposen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"Paulon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004037","name":"Juho Vainion S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022793","name":"Turku University Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"TYKS Turku University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neurobiolaging.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:58:45Z","timestamp":1781200725000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function \u2013 A 20-year follow-up study"],"prefix":"10.1016","volume":"167","author":[{"given":"Elina","family":"Pietil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Karrasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"Snellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Viitanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha O.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Ekblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00259-009-1174-1","article-title":"Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data","volume":"36","author":"Aalto","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib2","series-title":"Manual of directions and scoring","author":"Army Individual Test Battery","year":"1944"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.2025.12923","article-title":"Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial","volume":"334","author":"Baker","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-023-01355-x","article-title":"A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol","volume":"16","author":"Barbera","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.wnl.0000167607.63000.38","article-title":"A total score for the CERAD neuropsychological battery","volume":"65","author":"Chandler","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: A critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103551","article-title":"Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?","volume":"41","author":"Chen","year":"2024","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"Alzheimer\u2019s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib10","article-title":"Doctoral dissertation, Univerisyt of Turku]. University of Turku publication series","author":"Ekblad","year":"2017","journal-title":"Insul. Resist. Cogn. brain amyloid Accumul. Epidemiol. a positron Emiss. Tomogr. Study"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc16-2001","article-title":"Insulin resistance predicts cognitive decline: An 11-year follow-up of a nationally representative adult population sample","volume":"40","author":"Ekblad","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1212\/WNL.0000000000005214","article-title":"Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation","volume":"90","author":"Ekblad","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-122170","article-title":"Decline in cognitive function over 18 months in healthy older adults with high amyloid-\u03b2","volume":"34","author":"Ellis","year":"2013","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104927","article-title":"The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review","volume":"143","author":"Fanelli","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","article-title":"Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship","volume":"74","author":"Farrell","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib16","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) Cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fnagi.2019.00251","article-title":"Longitudinal Assessment of Amyloid-\u03b2 Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB across the spectrum of alzheimer\u2019s disease","volume":"11","author":"Hatashita","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib22","series-title":"Methodology report: Health 2000 Survey","author":"Heistaro","year":"2008"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib23","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1194\/jlr.M400250-JLR200","article-title":"Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample","volume":"45","author":"J\u00e4nis","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib25","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib26","doi-asserted-by":"crossref","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","article-title":"Temporal Dynamics of \u03b2-Amyloid Accumulation in Aging and Alzheimer Disease","volume":"96","author":"Jagust","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib27","series-title":"The Boston Naming Test","author":"Kaplan","year":"1983"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fninf.2020.00003","article-title":"Magia: robust automated image processing and kinetic modeling toolbox for PET Neuroinformatics","volume":"14","author":"Karjalainen","year":"2020","journal-title":"Front. Neuroinformatics"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib30","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/oby.23761","article-title":"Insulin resistance, cognition, and Alzheimer disease","volume":"31","author":"Kim","year":"2023","journal-title":"Obes. Silver Spring Md"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib31","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","article-title":"Memory decline accompanies subthreshold amyloid accumulation","volume":"90","author":"Landau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2013.11.005","article-title":"A\u03b2 and cognitive change: examining the preclinical and prodromal stages of Alzheimer\u2019s disease","volume":"10","author":"Lim","year":"2014","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib34","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3233\/JAD-161016","article-title":"Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease","volume":"57","author":"Lutski","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib37","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer\u2019s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer\u2019s Disease and Type 2 Diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib40","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2023.100074","article-title":"Longitudinal association between \u00df-amyloid accumulation and cognitive decline in cognitively healthy older adults: A systematic review","volume":"3","author":"Parent","year":"2023","journal-title":"Aging Brain"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106385","article-title":"Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [11C]PIB-PET study","volume":"190","author":"Pietil\u00e4","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/01.wnl.0000310646.32212.3a","article-title":"Impaired insulin secretion increases the risk of Alzheimer disease","volume":"71","author":"R\u00f6nnemaa","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: a cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neurobiolaging.2017.05.008","article-title":"Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model","volume":"57","author":"Snellman","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of Interference in Serial Verbal Reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J. Exp. Psychol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3673","article-title":"Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis","volume":"39","author":"Tian","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib48","doi-asserted-by":"crossref","unstructured":"Tingley, D., Yamamoto, T., Hirose, K., Keele, L., Imai, K., n.d. mediation: R Package for Causal Mediation Analysis. J. Stat. Soft. [Internet]. 2014 Sep. 2 [cited 2026 Apr. 27];59(5):1-38. Available from: https:\/\/www.jstatsoft.org\/index.php\/jss\/article\/view\/v059i05.","DOI":"10.18637\/jss.v059.i05"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-190691","article-title":"Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions","volume":"72","author":"Toppala","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib50","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1212\/WNL.0000000000011612","article-title":"Association of Early \u03b2-Amyloid Accumulation and Neuroinflammation Measured With [11C]PBR28 in Elderly Individuals Without Dementia","volume":"96","author":"Toppala","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-170153","article-title":"Midlife metabolic profile and the risk of late-life cognitive decline","volume":"59","author":"Tortelli","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib52","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/brain\/awx046","article-title":"Association between tau deposition and antecedent amyloid-\u03b2 accumulation rates in normal and early symptomatic individuals","volume":"140","author":"Tosun","year":"2017","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib54","series-title":"Wechsler Adult Intelligence Scale-Revised","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib55","series-title":"WMS-R: Wechsler Memory Scale-Revised: Manual","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2337\/dc12-0922","article-title":"Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults","volume":"36","author":"Willette","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib57","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.0000000000002593","article-title":"Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study","volume":"86","author":"Xiong","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/db08-0586","article-title":"Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2026.06.004_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:58:39Z","timestamp":1786474719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":59,"alternative-id":["S0197458026001132"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.06.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function \u2013 A 20-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}